Get the Stockscreener App
163.81
0.35%
-0.57
After Hours:
163.40
-0.41
-0.25%
State Street Spdr S P Biotech Etf stock is traded at $163.81, with a volume of 3.71M.
It is down -0.35% in the last 24 hours and up +7.85% over the past month.
See More
Previous Close:
$164.38
Open:
$162.74
24h Volume:
3.71M
Relative Volume:
0.42
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.88%
1M Performance:
+7.85%
6M Performance:
+29.58%
1Y Performance:
+75.25%
1-Day Range:
$162.51
$164.35
1-Week Range:
$159.62
$168.06
52-Week Range:
$92.64
$169.89
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Name
State Street Spdr S P Biotech Etf
Sector
Industry
Phone
-
Address
-
Compare XBI vs VTI, SPY, IVV, VB, QQQ
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
163.81 | 0 | 0 | 0 | 0 | 0.00 |
VTI
Vanguard Total Stock Market Etf
|
379.73 | 417.53B | 0 | 0 | 0 | 0.00 |
SPY
Spdr S P 500 Etf Trust
|
770.19 | 372.57B | 0 | 0 | 0 | 0.00 |
IVV
Ishares Core S P 500 Etf
|
773.92 | 253.41B | 0 | 0 | 0 | 0.00 |
VB
Vanguard Small Cap Etf
|
300.01 | 160.59B | 0 | 0 | 0 | 0.00 |
QQQ
Invesco Qqq Trust Series 1
|
718.96 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Stock (XBI) Latest News
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party? - 24/7 Wall St.
State Street SPDR S&P Biotech ETF (XBI) rated B... - Pluang
XBI: Big Pharma Can Keep The 76% Rally Going (NYSEARCA:XBI) - Seeking Alpha
Should You Invest in the VanEck Biotech ETF (BBH)? - Eastern Progress
Is State Street SPDR S&P Software & Services ETF (XSW) a Strong ETF Right Now? - Yahoo Finance
Biotech Is Popping. No One Seems to Care. - The Daily Upside
What's Going On With Novavax Stock? - Benzinga
The Next Biotech Boom May Be Cancer Vaccines. Watch These ETFsModerna (NASDAQ:MRNA) - Benzinga
Novavax Stock Climbs Monday: What's Going On? - Benzinga
XBI Forecast: $174.79 Tests Biotech ETF Breakout Strength - FXEmpire
Is State Street SPDR NYSE Technology ETF (XNTK) a Strong ETF Right Now? - Yahoo Finance
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy? - AOL.com
XBI: Biotech's Breakthrough Moment Happend This Week (Upgrade) (NYSEARCA:XBI) - Seeking Alpha
Moderna just gained $44 billion in value in a few hours - Opening Bell Daily
Merck, Moderna Cancer Vaccine Breakthrough Puts 4 ETFs In FocusMerck & Co (NYSE:MRK) - Benzinga
Biotechs hit a post-pandemic high after mRNA trial win for Moderna, Merck - Seeking Alpha
Novavax Stock Moves Higher Wednesday: What's Driving the Action? - Benzinga
Ishares Biotech ETF up 3.2%, State Street Spd - Moomoo
Healthcare ETFs Are Looking Up: Here's Why - cnhinews.com
XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets? - The Motley Fool
State Street XBI and First Trust FBT Offer Biotech ETF Options - sekbernews.id
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? - The Motley Fool
State Street SPDR S&P Biotech ETF (Derivatives): Latest News, Social Media Updates and Insights - CryptoRank
Should You Invest in the State Street SPDR S&P Software & Services ETF (XSW)? - Yahoo Finance
ETFs Investing in Arrowhead Pharmaceuticals, Inc. Stocks - TradingView
Biotechnology vs. Pharmaceuticals: What Are the Differences? - The Motley Fool
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - finance.yahoo.com
Sionna Therapeutics (NASDAQ:SION) Drops 92% After Failed Study, Shares Fall Below Gross Cash - TechStock²
iShares IXJ Competes Against State Street XBI in Healthcare ETF Battle - sekbernews.id
iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond? - The Motley Fool
Biotech Stocks: The New Drugs That Could Fuel Big Gains - Barron's
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026? - The Globe and Mail
State Street Health Care Select Sector SPDR ETF - ETF Database
Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI? - The Globe and Mail
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Uniqure NV (QURE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oric Pharmaceuticals Inc (ORIC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Verastem Inc (VSTM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Roivant Sciences Ltd (ROIV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AnaptysBio Inc (ANAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arrivent Biopharma Inc (AVBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Revolution Medicines Inc (RVMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Krystal Biotech Inc (KRYS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MannKind Corp (MNKD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CRISPR Therapeutics AG (CRSP) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Madrigal Pharmaceuticals Inc (MDGL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Incyte Corp (INCY) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Biomea Fusion Inc (BMEA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
INVESCO CANADIAN GOVERNMENT FL (PFL.NE) performance history - Yahoo Finance Singapore
Compass Therapeutics Inc. (CMPX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Travere Therapeutics Inc (TVTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
State Street Spdr S P Biotech Etf Stock (XBI) Financials Data
There is no financial data for State Street Spdr S P Biotech Etf (XBI). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.48%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):